PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Primary and Secondary endpoints met in MPS I Trial, page-11

  1. 905 Posts.
    lightbulb Created with Sketch. 277
    Was in jest.

    But, click refresh and you’ll see perhaps it was a little close to the truth…. Sell side volume picked right up.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.